Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
- Author
- Ashley Leak Bryant PhD RN OCN FAAN
- Published
- Mon 10 Jan 2022
- Episode Link
- https://oncologypodcast.simplecast.com/episodes/induction-and-maintenance-therapy-for-fit-patients-with-aml-without-targetable-mutations-wlX7veeA
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations. Topics include:
- Induction chemotherapy and consolidation therapy
- Use of gemtuzumab ozogamicin
- Management of sinusoidal obstruction syndrome
- Nursing considerations for younger, fit patients with AML
Presenter:
Ashley Leak Bryant, PhD, RN, OCN, FAAN
Associate Professor
School of Nursing
UNC Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
